Health

The largest pharmaceutical company in Britain has signed a deal to buy a French company that specializes in rare diseases for more than $1 billion. This is part of its efforts to boost the pipeline of drugs. AstraZeneca agreed to…

AstraZeneca will spend £650m to build a new factory for vaccines in Liverpool, and upgrade research labs at Cambridge. This comes almost a full year after the chief executive of AstraZeneca said that Rishi Sunak’s policies discouraged…

Smith & Nephew's revival is taking hold, according to the chief executive of the FTSE 100 medical products maker after it posted better-than expected fourth-quarter financial results. The underlying revenue increased by 6.4 percent…

The latest blow to London as a financial hub is the plan to relocate the primary listing of one of the largest anti-opioid companies in the world to the United States. Indivior, a FTSE 250 pharmaceuticals firm that specializes in…

One of Britain's largest drug companies secured a fast track review of a potentially blockbuster treatment of chronic hepatitis B. GSK announced that the US Food and Drug Administration has granted bepirovirsen an expedited approval…

Redx Pharma has decided to list in New York because it wants to tap into a wider and more specialized pool of investors. The latest blow for the City is that the London-listed Biotechnology Company, which has been through a turbulent…

Scientists shed new light on the spread of Alzheimer's disease in the brain, and discovered the first evidence that it can be transmitted between people via the now-banned growth hormone for humans. The study was published on Monday in…

Haleon sold ChapStick for more than $500m as it sought to reduce its debts while also boosting its stock price. The FTSE-100 company has agreed that it will sell its lip balms to Suave Brands for approximately $430 million cash plus a…

AstraZeneca wants up to £100m in government assistance to expand its vaccine production facility located in the northwest of England. The UK's largest public company, which is also the most valuable in the world, plans to submit an…

A study found that a simple blood test could detect the earliest signs of Alzheimer's. This has "huge implications" in screening people over 50 to determine their risk of the disease. Scientists from Sweden used a simple test kit,…

Superdrug's Christmas sales were boosted by the trend of people switching from expensive brands to own-label alternatives to reduce their rising living costs. The health and beauty retailer's sales grew 9.2 percent in December.…

GSK sold a Haleon stake worth approximately £1 billion on Tuesday evening as part of its plans to divest itself from the FTSE 100 consumer health care company. The British pharmaceuticals group Haleon has sold another 300 million shares,…

Like many married couples, Ugur Sahin and Ozlem Tureci work best as a double-act. Just as the duo were explaining how the German pharmaceutical company they founded, BioNTech, won the race to develop the Covid vaccine, Sahin leapt to his…

According to data from the European Health Agency, more than one billion dollars of Pfizer Covid-19 antiviral medications procured by Pfizer in Europe were wasted because strict controls on who could receive the medication led to millions…

Novo Nordisk wants to help more people get Wegovy jabs, including those who are currently unable to access them. Novo Nordisk, a maker of obesity drugs, said that it would offer countries the option to "buy now and pay later" for its…

AstraZeneca has contested accusations that the Covid-19 vaccine was "defective", after a vaccine patient sued for damages, claiming to have suffered a severe side-effect. The Anglo-Swedish pharmaceutical company, which developed the…

The NHS England announced Tuesday that US data analytics company Palantir had won a contract worth £330mn for the development of a new platform to store patient data. NHS England stated that the software called Federated Data Platform…

The landscape of vaccine technology is witnessing a revolutionary change with the introduction of TNX-1800, a next-generation COVID-19 vaccine developed by Tonix Pharmaceuticals. Led by CEO Dr. Seth Lederman, the company has made…